Reagent casing for detecting blood-lacking modification albumin and method thereof

Abstract

It is a detecting ischemia modified albumin (IMA) reagent kit and detection method, and the reagent kit contains different division to remove the background interference material device, which can be centrifugal ultrafiltration IMA detection reagent kit, immunomagnetic beads IMA detection reagent kit, immunochromatography IMA detection reagent kit, immune chromatography membrane IMA detection board reagent kit or immune membrane filtration plate IMA detection reagent kit. After division removal of the background interference material, it can enhance the specific of detection IMA reagent kit and detection method, and using this reagent kit and hospital existing equipments, in about half an hour, it can measure the IMA value to diagnosis myocardial ischemia symptoms. Particularly suitable for bedside rapid detection kit development, ease to use, low cost, it is a very development promising product.

Description

field of invention

[0001] The invention relates to a kit for detecting ischemic modified albumin and a detection method thereof. This type of kit uses the albumin cobalt binding test to detect cobalt ions that are not bound to human albumin after removing the background interference of albumin, and the obtained value can be used to diagnose whether the patient has symptoms of myocardial ischemia. technical background

[0002] Acute Coronary Syndrome (ACS) is a large category of diseases that cause chest discomfort and other symptoms due to acute myocardial ischemia. It is a common clinical heart and vascular emergency and is also the main cause of acute death. ACS covers a group of progressive diseases, including Unstable Angina (UA), Non-ST Segment Elevation Myocardial Infarction (NSTEMI), ST Segment Elevation Myocardial Infarction (referred to as STEMI) and sudden cardiac death. The pathological basis of ACS is the thrombosis of unstable plaques in the coronary arteries....

Images